Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biology and Molecular Pathogenesis of Mature T-Cell Lymphomas
José R. Cortés, Teresa Palomero
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 5, pp. a035402-a035402
Open Access | Times Cited: 15

Showing 15 citing articles:

TET-Mediated Epigenetic Regulation in Immune Cell Development and Disease
Nikolas James Tsiouplis, David Wesley Bailey, Lilly Chiou, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 44
Clinical Impact of Next-Generation Sequencing of T-cell Lymphomas: A Single Institution Experience
Omar Elghawy, Julia T. Wang, Olivia J Leung, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma
José R. Cortés, Ioan Filip, Robert Alberó, et al.
Cell Reports (2022) Vol. 39, Iss. 3, pp. 110695-110695
Open Access | Times Cited: 18
TET proteins regulate T cell and iNKT cell lineage specification in a TET2 catalytic dependent manner
Tarmo Äijö, Dimitris Theofilatos, Meng Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
TET Proteins in the Spotlight: Emerging Concepts of Epigenetic Regulation in T Cell Biology
Ageliki Tsagaratou
ImmunoHorizons (2023) Vol. 7, Iss. 1, pp. 106-115
Open Access | Times Cited: 5
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients
Luís Alberto de Pádua Covas Lage, Guilherme Carneiro Barreto, Hebert Fabrício Culler, et al.
Cancer Biomarkers (2022) Vol. 35, Iss. 2, pp. 179-191
Closed Access | Times Cited: 8
Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
Rahul S. Bhansali, Stefan K. Barta
Cancers (2023) Vol. 15, Iss. 3, pp. 925-925
Open Access | Times Cited: 4
Molecular Genetics in Epstein–Barr Virus-Associated Malignancies
Srikanth Umakanthan, Maryann M Bukelo
Life (2021) Vol. 11, Iss. 7, pp. 593-593
Open Access | Times Cited: 7
Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies
Till Braun, Alexandra Schrader
Cancers (2023) Vol. 15, Iss. 9, pp. 2532-2532
Open Access | Times Cited: 2
Generation of Inducible BCL11B Knockout in TAL1/LMO1 Transgenic Mouse T Cell Leukemia/Lymphoma Model
Grzegorz K. Przybylski, Dorota Korsak, Katarzyna Iżykowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4932-4932
Open Access | Times Cited: 3
Discovery of molecularly-informed therapeutic strategies for mature T-cell neoplasms
Raphael Koch, Nicole Schmidt, Kevin Kornrumpf, et al.
Research Square (Research Square) (2024)
Open Access
Concomitant loss of TET2 and TET3 results in T cell expansion and genomic instability in mice
Marianthi Gioulbasani, Tarmo Äijö, Siyao Liu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Epigenetic targets in B- and T-cell lymphomas: latest developments
Marcelo Lima Ribeiro, Salvador Sánchez-Vinces, Laura Mondragón, et al.
Therapeutic Advances in Hematology (2023) Vol. 14
Open Access | Times Cited: 1
TCR Pathway Mutations in Mature T Cell Lymphomas
Yue Zhang, Kathleen Cheng, Jaehyuk Choi
The Journal of Immunology (2023) Vol. 211, Iss. 10, pp. 1450-1458
Open Access | Times Cited: 1
The peripheral T-cell lymphoma: can we pivot from the chemotherapy-predicated paradigm?
Helen Ma, Enrica Marchi
Journal of Cancer Metastasis and Treatment (2022) Vol. 8, Iss. 5, pp. 25-25
Open Access
Page 1

Scroll to top